Koers Spring Pharmaceutical Group, Inc.
Aandelen
BYC
US84987P1057
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Chuan Min Li
DFI | Director of Finance/CFO | 59 | 01-01-05 |
Qiang Zhang
ADM | Chief Administrative Officer | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Ji Rui Zhang
BRD | Director/Board Member | 68 | 01-01-04 |
Director/Board Member | 73 | 06-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,51% | 728 mld. | |
+33,05% | 603 mld. | |
-6,23% | 360 mld. | |
+18,78% | 332 mld. | |
+1,35% | 279 mld. | |
+16,00% | 244 mld. | |
+8,09% | 207 mld. | |
-5,77% | 205 mld. | |
+6,19% | 164 mld. |